Surgery Partners, Inc. (NASDAQ:SGRY) Insider Sells $1,443,916.60 in Stock

Surgery Partners, Inc. (NASDAQ:SGRY) insider Harrison R. Bane sold 56,315 shares of the company’s stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.64, for a total value of $1,443,916.60. Following the sale, the insider now directly owns 107,037 shares of the company’s stock, valued at $2,744,428.68. The trade was a 34.47 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Surgery Partners Stock Performance

SGRY opened at $25.35 on Thursday. The stock’s 50 day simple moving average is $21.99 and its 200-day simple moving average is $26.84. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The stock has a market cap of $3.22 billion, a PE ratio of -52.81, a P/E/G ratio of 17.77 and a beta of 2.60. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $35.29.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. During the same period last year, the firm earned $0.15 EPS. The company’s quarterly revenue was up 14.3% compared to the same quarter last year. Sell-side analysts forecast that Surgery Partners, Inc. will post 0.71 EPS for the current year.

Institutional Trading of Surgery Partners

Several institutional investors have recently made changes to their positions in the business. Principal Financial Group Inc. bought a new position in Surgery Partners during the third quarter worth about $1,469,000. King Street Capital Management L.P. acquired a new position in shares of Surgery Partners in the 3rd quarter worth approximately $46,748,000. Royce & Associates LP lifted its position in shares of Surgery Partners by 12.2% during the 3rd quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock worth $16,451,000 after buying an additional 55,545 shares during the period. Geode Capital Management LLC boosted its stake in Surgery Partners by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock valued at $60,117,000 after buying an additional 42,897 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its stake in Surgery Partners by 140.4% in the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after buying an additional 777,038 shares in the last quarter.

Wall Street Analyst Weigh In

SGRY has been the subject of several recent analyst reports. Royal Bank of Canada decreased their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday, November 20th. Bank of America began coverage on shares of Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 price target for the company. Macquarie reaffirmed an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a research report on Tuesday, November 19th. Finally, JPMorgan Chase & Co. cut their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $36.56.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.